Invasive fungal infections in children

Pediatric Infectious Disease Journal

Volumn 28, Issue 8, 2009, Pages 734-737

  Dornbusch, Hans Jürgen ^a   Manzoni, Paolo ^b   Roilides, Emmanuel ^c   Walsh, Thomas J ^d   Groll, Andreas H ^e  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b S ANNA HOSPITAL   (Italy)

^c ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Antifungals; Fungus; Opportunistic infections

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE; FUNGAL DNA; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ASPERGILLOSIS; CANDIDIASIS; CELL WALL; CHILDHOOD DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUSARIOSIS; HUMAN; MUCORMYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; ULTRASOUND;

EID: 68649096437     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181b076b1     Document Type: Review

References (55)

1. Steinbach WJ, Walsh TT. Mycoses⋯. Infect Dis Clin North Am. 2006;20:663-678.
2. Chiou CC, et al. Clinical phannacology⋯. Expert Opin Pharmacother. 2007;8:2465-2489.
3. Filioti J, et al. Invasive candidiasis⋯. Intensive Care Med. 2007;33:1272-1283.
4. Zaoutis TE, et al. The epidemiology and attributable⋯. Clin Infect Dis. 2005;41:1232-1239.
5. Zaoutis TE, et al. Outcomes attributable⋯. Clin Infect Dis. 2007;44:1187-1193.
6. Benjamin DK Jr., et al. Candida bloodstream infection⋯. Semin Perinatol. 2003;27:375-383.
7. Burgos A, et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis. Pediatrics. 2008;121:e1286-1294.
8. Zaoutis TE, et al. Epidemiology, outcomes, and costs⋯. Pediatrics. 2006;117:e711-716.
9. Almyroudis NG, et al. Invasive aspergillosis⋯. Med Mycol. 2005;43(Suppl 1):S247-259.
10. Zaoutis TE, et al. Zygomycosis in children. Pediatr Infect Dis J. 2007;26:723-727.
11. Roilides E, et al. Zygomycosis in neonates⋯. Am J Perinatol. 2009 Apr 23 (e-published ahead of print).
12. Walsh TJ, et al. Infections due to emerging⋯. Clin Microbiol Infect. 2004;10(Suppl 1):48-66.
13. Gonzalez CE, et al. Cryptococcosis in HIV-in-fected children. Pediatr Infect Dis J. 1996;15: 796-800.
14. Mennink-Kersten M, Verweij PE. Non-culture-based diagnostics⋯. Infect Dis Clin N Am 2006;20: 711-727.
15. Caillot D, et al. Improved management. J Clin Oncol. 1997;15:139-147.
16. Thomas K, et al. The radiological spectrum⋯. Pediatr Radiol. 2003;33(7):453-460.
17. Roilides E. Early diagnosis⋯. Med Mycol. 2006; 44:S199-205.
18. Groll AH, Walsh TJ. Antifungal chemotherapy⋯. Swiss Med Wkly 2002;132:303-311.
19. DePauw B, et al. Revised definitions of invasive fungal disease⋯. Clin Infect Dis. 2008;46:1813-1821.
20. Hayden R, et al. Galactomannan antigenemia⋯. Pediatr Infect Dis J. 2008;27(9):815-819.
21. Desai R, et al. The role of bronchoalveolar lavage galactomannan⋯. Pediatr Infect Dis J. 2009;28: 283-286.
22. Odabasi Z, et al. Beta-D-glucan as a diagnostic⋯. Clin Infect Dis. 2004;39:199-205.
23. Mengoli C, et al. Use of PCR for diagnosis⋯. Lancet Infect Dis. 2009;9:89-96.
24. Hebart H, et al. A prospective randomized controlled trial⋯. Bone Marrow Transpl. 2009;43: 553-561.
25. Lass-Floerl C, et al. The value of computed tomography-guided⋯. Clin Infect Dis. 2007;45:e101-104.
26. Zaoutis TE, et al. A prospective, multicenter study of caspoiungin⋯. Pediatrics. 2009;123:877-84.
27. Queiroz-Telles F, et al. Micafungin versus liposomal amphotericin B⋯. Pediatr Infect Dis J. 2008;27(9):820-826.
28. Groll AH, et al. Recent advances⋯. Sem Hematol. 2009 (in press)
29. Pappas PG, et al. Clinical practice guidelines⋯. Clin Infect Dis. 2009;48:503-535.
30. Wiley JM, et al. Efficacy and safety of amphotericin B lipid complex⋯. Pediatr Infect Dis J. 2005;24:167-174.
31. Walsh TJ, et al. Voriconazole⋯. Pediatr Infect Dis J. 2002;21:240-248.
32. Walsh TJ, et al. Treatment of aspergillosis⋯. Clin Infect Dis. 2008;46:327-360.
33. Herbrecht R, et al. Voriconazole versus amphotericin B⋯. N Engl J Med 2002;347:408-415.
34. Comely OA, et al. Liposomal amphotericin B⋯. Clin Infect Dis. 2007;44:1289-1297.
35. Maertens J, et al. Efficacy and safety of caspofungin⋯. Clin Infect Dis. 2004;39:1563-1571.
36. Wirk B, Wingard JR. Combination antifungal therapy⋯. Current Fungal Infection Reports. 2008;2:43-48.
37. Perfect JR, et al. Voriconazole treatment⋯. Clin Infect Dis. 2003;36:1122-31.
38. th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington DC: Abstr. M-669; Washington, DC (2004).
39. van Burik JA, et al. Posaconazole⋯. Clin Infect Dis. 2006;42:e61-65.
40. Prentice HG, et al. A randomized comparison of liposomal versus conventional amphotericin B⋯. Br J Haematol. 1997;98:711-718.
41. th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington DC 2007: Abstr. M-621, page 435.
42. van Burik JA, et al. Micafungin versus fluconazole⋯. Clin Infect Dis. 2004;39:1407-1416.
43. Wingard JR, et al. Results of a randomized, double-blind trial of fluconazole (FLU) vs. voriconazole (VORI)⋯. Blood 2007;110:235(ab-stract).
44. Ullmann AJ, et al. Posaconazole or fluconazole⋯. N Engl J Med 2007;356:335-347.
45. Cornely OA, et al. Posaconazole vs. fluconazole or itraconazole⋯. N Engl J Med. 2007;356:348-359.
46. Krishna G, et al. Posaconazole plasma concentrations⋯. Antimicrob Agents Chemother. 2007;51:812-818.
47. Penack O, et al. Low-dose liposomal amphotericin B⋯. Ann Oncol. 2006;17:1306-1312.
48. Stoll BJ, et al. Neurodevelopmental and growth impairment⋯. JAMA. 2004;292:2357-2365.
49. Manzoni P, et al. Oral supplementation with Lacibacillus⋯. Clin Infect Dis 2006;42:1735-1742.
50. Kicklighter SD, et al. Fluconazole for prophylaxis⋯. Pediatrics. 2001;107:293-298.
51. Kaufman D, et al. Fluconazole prophylaxis⋯. N Engl J Med. 2001;345:1660-1666.
52. Kaufman D, et al. Twice weekly fluconazole prophylaxis⋯. J Pediatr. 2005;147:172-179.
53. Manzoni P, et al. A Multicenter, Randomized Trial of Prophylactic Fluconazole⋯. N Engl J Med 2007;356:2483-2495.
54. Manzoni P, et al. Routine use of fluconazole prophylaxis⋯. Pediatr Infect Dis J. 2008;27: 731-737.
55. Kaufman DA, et al. Update on antifungal sensitivities⋯. E-PAS 2008: 633758.10.